首页> 外国专利> Procedure for the preparation of new pseudotrisacaridos. (Machine-translation by Google Translate, not legally binding)

Procedure for the preparation of new pseudotrisacaridos. (Machine-translation by Google Translate, not legally binding)

机译:新的拟假三头孢菌的制备程序。 (通过Google翻译进行机器翻译,没有法律约束力)

摘要

Procedure for the preparation of new pseudotrisaccharides, particularly 1-N substituted derivatives of 4,6-di- (aminoglycosyl) -1,3-diaminocyclitols gentamicin A, gentamicin B, gentamicin B1, gentamicin C1, gentamicin C1a, gentamicin C2, Gentamicin C2a, Gentamicin C2b, Gentamicin X2, Sisomycin, Verdamicin, Tobramycin, G-418 Antibiotic, 66-40B Antibiotic, JI-20A Antibiotic, JI-20B Antibiotic, G-52 Antibiotic, Mutamycin 1,, mutamicin 4, mutamicin 5 and mutamicin 6, in which the substituent is **(See formula)** where X is hydrogen, alcoholic, alkenyl, cycloalkyl, cycloalkoxylalkyl, hydroxyalkyl, aminoalcohyl, N-alcoholylaminoalcohyl, aminohydroxyalkyl, N-alcoholylaminohydroxyalkyl, phenyl, benzyl or tolyl, with said aliphatic radicals being up to seven carbon atoms and, if, and, if, they are aliphatic radicals with and if hydroxy, bearing the substituents on different carbon atoms, and of the pharmaceutically acceptable acid addition salts thereof, which method comprises treating one of the 4, 6-di- (aminoglycosyl) -1,3-diamino-cyclitols mentioned above which may have amino protecting groups at any position other than position 1, with an aldehyde of the formula **(See formula)** where X is a group as defined above for X in which any amino or hydroxy group present may be protected, in the presence of a hydride donor reducing agent and, if required, remove all protecting groups present in the molecule, being followed by the last step of the process by isolation of the derivative as is or in the form of a pharmaceutically acceptable acid addition salt. (Machine-translation by Google Translate, not legally binding)
机译:制备新的假三糖的方法,特别是4,6-二-(氨基糖基)-1,3-二氨基环糖醇的庆大霉素A,庆大霉素B,庆大霉素B1,庆大霉素C1,庆大霉素C1a,庆大霉素C2,庆大霉素C2a的1-N取代衍生物,庆大霉素C2b,庆大霉素X2,西霉素,维达霉素,妥布霉素,G-418抗生素,66-40B抗生素,JI-20A抗生素,JI-20B抗生素,G-52抗生素,Mutamycin 1,mutamicin 4,mutamicin 5和mutamicin 6 ,其中取代基是**(参见式)**,其中X是氢,醇基,烯基,环烷基,环烷氧基烷基,羟基烷基,氨基醇基,N-醇基氨基醇基,氨基羟基烷基,N-醇基氨基羟烷基,苯基,苄基或甲苯基,最多包含七个碳原子的基团,以及在药学上可接受的酸加成盐中,如果有的话,以及如果是含羟基的脂肪族基团,以及在药学上可接受的酸加成盐,则该方法包括处理以下一种上面提到的4,6-二-(氨基糖基)-1,3-二氨基-环醇,可以在除位置1以外的任何位置具有氨基保护基,并带有式**(参见式)**的醛,其中X是如上对于X所定义的基团,其中在氢化物供体还原剂的存在下,存在的任何氨基或羟基可以被保护,并且如果需要,除去分子中存在的所有保护基,然后进行最后的步骤。通过以原样或以药学上可接受的酸加成盐形式分离衍生物的方法。 (通过Google翻译进行机器翻译,没有法律约束力)

著录项

  • 公开/公告号ES428892A1

    专利类型

  • 公开/公告日1977-02-16

    原文格式PDF

  • 申请/专利权人 SCHERICO LTD.;

    申请/专利号ES19740428892

  • 发明设计人

    申请日1974-08-02

  • 分类号C08B;C07D;

  • 国家 ES

  • 入库时间 2022-08-23 00:31:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号